Miller Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Hold
7,586
0.15% 38
2025
Q4
$1.32M Hold
7,586
0.13% 47
2025
Q3
$1.45M Hold
7,586
0.15% 48
2025
Q2
$1.36M Hold
7,586
0.14% 53
2025
Q1
$1.28M Hold
7,586
0.14% 56
2024
Q4
$1.14M Sell
7,586
-5,567
-42% -$866K 0.13% 62
2024
Q3
$2.04M Hold
13,153
0.21% 45
2024
Q2
$1.8M Hold
13,153
0.22% 48
2024
Q1
$1.75M Hold
13,153
0.22% 47
2023
Q4
$1.81M Hold
13,153
0.26% 44
2023
Q3
$1.6M Hold
13,153
0.25% 43
2023
Q2
$1.85M Hold
13,153
0.28% 42
2023
Q1
$1.86M Hold
13,153
0.31% 37
2022
Q4
$2.06M Hold
13,153
0.35% 34
2022
Q3
$1.61M Hold
13,153
0.34% 35
2022
Q2
$1.75M Hold
13,153
0.36% 36
2022
Q1
$1.8M Hold
13,153
0.28% 45
2021
Q4
$2.28M Hold
13,153
0.33% 35
2021
Q3
$1.91M Hold
13,153
0.33% 35
2021
Q2
$1.74M Buy
13,153
+548
+4% +$71.7K 0.3% 32
2021
Q1
$1.62M Buy
12,605
+1,105
+10% +$136K 0.3% 32
2020
Q4
$1.37M Hold
11,500
0.26% 33
2020
Q3
$1.32M Hold
11,500
0.32% 28
2020
Q2
$1.31M Hold
11,500
0.39% 27
2020
Q1
$923K Sell
11,500
-1,426
-11% -$148K 0.3% 35
2019
Q4
$1.38M Sell
12,926
-1,600
-11% -$167K 0.31% 36
2019
Q3
$1.55M Sell
14,526
-3,854
-21% -$396K 0.35% 34
2019
Q2
$1.87M Buy
18,380
+11,551
+169% +$1.11M 0.43% 27
2019
Q1
$614K Hold
6,829
0.16% 49
2018
Q4
$569K Hold
6,829
0.17% 49
2018
Q3
$737K Sell
6,829
-1,875
-22% -$206K 0.22% 46
2018
Q2
$957K Buy
+8,704
New +$907K 0.29% 43

Other funds holding DGX

Miller Investment Management's DGX Position: Q1 2026 in Review

Miller Investment Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 7,586 shares worth $1.49M. The position accounts for 0.15% of the portfolio, ranked #38.

Miller Investment Management first reported a position in DGX in Q2 2018 and has held it in 32 quarters since. The position peaked at $2.28M in Q4 2021. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Miller Investment Management held 7,586 shares of Quest Diagnostics worth $1.49M as of Q1 2026.
  • Miller Investment Management left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.15% of Miller Investment Management's portfolio in Q1 2026, its #38 holding.
  • Miller Investment Management first reported a position in Quest Diagnostics in Q2 2018 and has held it in 32 quarters since.
  • Miller Investment Management's Quest Diagnostics position peaked at $2.28M in Q4 2021.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Miller Investment Management's 13F filing for Q1 2026, filed 8 May 2026.